If a major drug company does trials, perhaps all the way through PIII, then transfers the entire data set to GLGC for additional analysis, I call that a significant commitment and requires significant trust and, BTW I know for a fact that it cost them significant money.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.